PT1093366E - Composicao farmaceutica que contem analogos de gaba e um agente antiviral para o tratamento de herpes zoster - Google Patents
Composicao farmaceutica que contem analogos de gaba e um agente antiviral para o tratamento de herpes zosterInfo
- Publication number
- PT1093366E PT1093366E PT99930482T PT99930482T PT1093366E PT 1093366 E PT1093366 E PT 1093366E PT 99930482 T PT99930482 T PT 99930482T PT 99930482 T PT99930482 T PT 99930482T PT 1093366 E PT1093366 E PT 1093366E
- Authority
- PT
- Portugal
- Prior art keywords
- agent
- antibiral
- treatment
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical class NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 title abstract 3
- 208000007514 Herpes zoster Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 abstract 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 abstract 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract 1
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 abstract 1
- 235000013922 glutamic acid Nutrition 0.000 abstract 1
- 239000004220 glutamic acid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Biotechnology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9217198P | 1998-07-09 | 1998-07-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1093366E true PT1093366E (pt) | 2005-02-28 |
Family
ID=22231986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT99930482T PT1093366E (pt) | 1998-07-09 | 1999-06-18 | Composicao farmaceutica que contem analogos de gaba e um agente antiviral para o tratamento de herpes zoster |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1093366B1 (https=) |
| JP (1) | JP2002520300A (https=) |
| KR (1) | KR20010071776A (https=) |
| AT (1) | ATE279188T1 (https=) |
| AU (1) | AU765246B2 (https=) |
| CA (1) | CA2332929C (https=) |
| DE (1) | DE69921137T2 (https=) |
| DK (1) | DK1093366T3 (https=) |
| ES (1) | ES2230863T3 (https=) |
| ID (1) | ID27395A (https=) |
| NO (1) | NO20010116L (https=) |
| NZ (2) | NZ508489A (https=) |
| PL (1) | PL345337A1 (https=) |
| PT (1) | PT1093366E (https=) |
| SI (1) | SI1093366T1 (https=) |
| WO (1) | WO2000002592A1 (https=) |
| ZA (1) | ZA200007169B (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60022333T2 (de) | 1999-04-09 | 2006-07-06 | Euro-Celtique S.A. | Natrium kanalblocker zusammensetzungen und deren verwendung |
| US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| IL160523A0 (en) | 2001-09-03 | 2004-07-25 | Newron Pharm Spa | PHARMACEUTICAL COMPOSITION COMPRISING GABAPENTIN OR AN ANALOGUE THEREOF AND AN alpha-AMINOAMIDE AND ITS ANALGESIC USE |
| EP1963280B1 (en) | 2005-12-22 | 2015-10-28 | Newron Pharmaceuticals S.p.A. | 2-phenylethylamino derivatives as calcium and/or sodium channel modulators |
| MX2007006093A (es) * | 2007-05-21 | 2009-02-25 | World Trade Imp Export Wtie Ag | Composicion farmaceutica que comprende la combinacion de un agente anticonvulsivo y un agente antiviral. |
| KR20160095358A (ko) | 2015-02-03 | 2016-08-11 | 고려대학교 산학협력단 | 우고닌 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 함유하는 헤르페스 바이러스 감염 질환의 예방 또는 치료용 약학적 조성물 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL111138A (en) * | 1993-10-05 | 1997-04-15 | Smithkline Beecham Plc | Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia |
| GB9321394D0 (en) * | 1993-10-16 | 1993-12-08 | Smihtkline Beecham P L C | Pharmaceuticals |
| WO1997033859A1 (en) * | 1996-03-14 | 1997-09-18 | Warner-Lambert Company | Novel bridged cyclic amino acids as pharmaceutical agents |
| IL126999A (en) * | 1996-07-24 | 2002-03-10 | Warner Lambert Co | Pharmaceutical preparations containing isobutylgaba and its history for use in the treatment of pain |
-
1999
- 1999-06-18 EP EP99930482A patent/EP1093366B1/en not_active Expired - Lifetime
- 1999-06-18 DE DE69921137T patent/DE69921137T2/de not_active Expired - Fee Related
- 1999-06-18 PT PT99930482T patent/PT1093366E/pt unknown
- 1999-06-18 DK DK99930482T patent/DK1093366T3/da active
- 1999-06-18 KR KR1020017000253A patent/KR20010071776A/ko not_active Ceased
- 1999-06-18 PL PL99345337A patent/PL345337A1/xx not_active IP Right Cessation
- 1999-06-18 WO PCT/US1999/013947 patent/WO2000002592A1/en not_active Ceased
- 1999-06-18 ES ES99930482T patent/ES2230863T3/es not_active Expired - Lifetime
- 1999-06-18 JP JP2000558851A patent/JP2002520300A/ja not_active Withdrawn
- 1999-06-18 SI SI9930696T patent/SI1093366T1/xx unknown
- 1999-06-18 ID IDW20010053A patent/ID27395A/id unknown
- 1999-06-18 NZ NZ508489A patent/NZ508489A/en unknown
- 1999-06-18 NZ NZ525623A patent/NZ525623A/en not_active Application Discontinuation
- 1999-06-18 AU AU47016/99A patent/AU765246B2/en not_active Ceased
- 1999-06-18 CA CA002332929A patent/CA2332929C/en not_active Expired - Fee Related
- 1999-06-18 AT AT99930482T patent/ATE279188T1/de not_active IP Right Cessation
-
2000
- 2000-12-04 ZA ZA200007169A patent/ZA200007169B/en unknown
-
2001
- 2001-01-08 NO NO20010116A patent/NO20010116L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200007169B (en) | 2002-03-04 |
| PL345337A1 (en) | 2001-12-17 |
| NO20010116D0 (no) | 2001-01-08 |
| ES2230863T3 (es) | 2005-05-01 |
| DK1093366T3 (da) | 2004-12-06 |
| ID27395A (id) | 2001-04-05 |
| CA2332929A1 (en) | 2000-01-20 |
| JP2002520300A (ja) | 2002-07-09 |
| AU4701699A (en) | 2000-02-01 |
| SI1093366T1 (en) | 2005-02-28 |
| EP1093366B1 (en) | 2004-10-13 |
| EP1093366A1 (en) | 2001-04-25 |
| NZ525623A (en) | 2005-08-26 |
| KR20010071776A (ko) | 2001-07-31 |
| AU765246B2 (en) | 2003-09-11 |
| NO20010116L (no) | 2001-01-08 |
| CA2332929C (en) | 2005-05-31 |
| DE69921137T2 (de) | 2006-02-02 |
| ATE279188T1 (de) | 2004-10-15 |
| NZ508489A (en) | 2004-06-25 |
| WO2000002592A1 (en) | 2000-01-20 |
| DE69921137D1 (de) | 2004-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL338705A1 (en) | Application of gaba analogues in preventing and treating gastrointestinal diseases | |
| ES2159851T3 (es) | Amidas de acidos aminotiofenocarboxilicos y su empleo como inhibidores de la fosfodiestearasa. | |
| BR9809115A (pt) | Métodos para tratar inflamação e doenças inflamatórias usando inibidores de padprt | |
| MX168000B (es) | Complemento dietetico que contiene beta-glucan complemento | |
| ES2188656T3 (es) | Composicion antiviral para la cicatrizacion de una herida que contiene un piruvato, un antioxidante, una mezcla de acidos grasos saturados y un compuesto antiviral. | |
| ES2176502T3 (es) | Derivados de hidroxilamina utiles para mejorar la pproduccion de chaperonas moleculares su su preparacion. | |
| IS4576A (is) | Lyfjasamsetning sem inniheldur prótónudælulata | |
| BR9800932A (pt) | Enriquecimento de alimentos. | |
| EP0668933A4 (en) | USE OF METHIONINASE AS AN ANTI-TUMOR MEDICINE IN ANTIMETHIONIN CHEMOTHERAPY. | |
| DK0696456T3 (da) | Kombination af nekrosefremkaldende stoffer med stoffer, som aktiveres af nekroser, til selektiv behandling af tumorer og betændelsessygdomme | |
| ES2145417T3 (es) | Procedimiento para la preparacion de soluciones de sales de aluminio. | |
| IS2789B (is) | Lyfjablöndur sem innihalda mónóamínoxídasa B hemla | |
| PT1093366E (pt) | Composicao farmaceutica que contem analogos de gaba e um agente antiviral para o tratamento de herpes zoster | |
| BR0008829A (pt) | Inibição sinérgica de replicação viral porhidrocarbonetos de cadeia longa e análogos denucleosìdeos | |
| BR9814711A (pt) | Composições e processos para aumentar a concentração e/ou motilidade de espermatozóides em seres humanos | |
| DK0994704T3 (da) | Anvendelse af GABA-analoger såsom gabapentin i fremstillingen af et medikament til behandling af inflammatoriske sygdomme | |
| DK1032378T3 (da) | Anvendelse af en blanding af en diol og en alfa-hydroxysyre til behandling af hyperkeratosiske hudsygdomme | |
| BR9916156A (pt) | Método e composição para a manutenção e restituição de integridade do intestino | |
| ES2183158T3 (es) | Poli(acidos organicos) y sus analogos para aumentar la eficacia herbicida. | |
| BR9911950A (pt) | Composição farmacêutica contendo análogos gaba e um agente antiviral para tratamento de herpes zoster | |
| KR890000399A (ko) | (e)-2-(p-플루오로펜에틸)-3-플루오로알릴아민 | |
| BR9911943A (pt) | Composições compreendendo análogos gaba e um descongestionante para aliviar dor de cabeça de sino | |
| AR038224A1 (es) | Empleo de alquilfosfocolinas en el tratamiento preventivo de enfermedades causadas por protozoarios | |
| AR008764A1 (es) | Sales hidratadas de n,n'-diacetilcistina, proceso para su preparacion, y composiciones terapeuticas que comprenden a dichas sales como ingredienteactivo. | |
| BR9608721A (pt) | Composição farmacêutica, e, processo para tratar inflamação |